subject area of
- A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the Prevention of Syncope Trial VI Academic Article
- Age of First Faint in Patients with Vasovagal Syncope Academic Article
- Atrial Fibrillation Causing Syncope? Academic Article
- Beta-blockers in syncope: the jury is still out Academic Article
- Central serotoninergic response to orthostatic challenge in patients with neurocardiogenic syncope Academic Article
- Diagnostic criteria for vasovagal syncope based on a quantitative history Academic Article
- Effect of Metoprolol on Quality of Life in the Prevention of Syncope Trial Academic Article
- North American Vasovagal Pacemaker Study: Study Design and Organization Academic Article
- Pacemaker Therapy for Prevention of Syncope in Patients With Recurrent Severe Vasovagal Syncope Academic Article
- Prevention of Syncope Trial (POST) Academic Article
- Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope Rationale and study design Academic Article
- Second Vasovagal Pacemaker Study (VPS II): Rationale, Design, Results, and Implications for Practice and Future Clinical Trials Academic Article
- The North American vasovagal pacemaker study (VPS) §§A list of members appears in the Appendix.22Editorials published in Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. Academic Article
- Treatment of Neurally Mediated Reflex Syncope Academic Article
- Usefulness of the Calgary Syncope Symptom Score for the diagnosis of vasovagal syncope in the elderly Academic Article
- Worsening of Symptoms Before Presentation with Vasovagal Syncope Academic Article